LPS/TLR4-mediated stromal cells acquire an invasive phenotype and are implicated in the pathogenesis of adenomyosis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Guo, Jing ^a   Chen, Li ^a   Luo, Ning ^a   Li, Caixia ^a   Chen, Rong ^a   Qu, Xiaoyan ^a   Liu, Mingmin ^a   Kang, Le ^a   Cheng, Zhongping ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4;

ADENOMYOSIS; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECTS; ENDOMETRIUM; FEMALE; GENETICS; HUMAN; INFLAMMATION; METABOLISM; NEOPLASMS; PATHOLOGY; SIGNAL TRANSDUCTION; STROMA CELL; TUMOR INVASION;

ADENOMYOSIS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; ENDOMETRIUM; FEMALE; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; NEOPLASM INVASIVENESS; NEOPLASMS; SIGNAL TRANSDUCTION; STROMAL CELLS; TOLL-LIKE RECEPTOR 4;

EID: 84959449674     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21416     Document Type: Article

References (57)

1. Ferenczy, A. Pathophysiology of adenomyosis. Hum Reprod Update 4, 312-322 (1998).
2. Korzekwa, A., Lupicka, M., Socha, B., Mannelli, C., Skarzynski, D. J. Is adenomyosis a problem in reproduction and fertility? Pol J Vet Sci 17, 187-194 (2014).
3. Lee, J. Y. et al. Uterine infarction in a patient with uterine adenomyosis following biochemical pregnancy. Clin Exp Reprod Med 41, 174-177 (2014).
4. Di Donato, N., Seracchioli, R. How to evaluate adenomyosis in patients affected by endometriosis? Minim Invasive Surg 2014, 507230 (2014).
5. Benagiano, G., Brosens, I. History of adenomyosis. Best Pract Res Clin Obstet Gynaecol 20, 449-463 (2006).
6. Exacoustos, C., Manganaro, L., Zupi, E. Imaging for the evaluation of endometriosis and adenomyosis. Best Pract Res Clin Obstet Gynaecol 28, 655-681 (2014).
7. Zhang, Y. et al. Ultrastructural features of endometrial-myometrial interface and its alteration in adenomyosis. Int J Clin Exp Pathol 7, 1469-1477 (2014).
8. Garcia, L., Isaacson, K. Adenomyosis: Review of the literature. J Minim Invasive Gynecol 18, 428-437 (2011).
9. Javert, C. T. The spread of benign and malignant endometrium in the lymphatic system with a note on coexisting vascular involvement. Am J Obstet Gynecol 64, 780-806 (1952).
10. Leyendecker, G., Wildt, L., Mall, G. The pathophysiology of endometriosis and adenomyosis: Tissue injury and repair. Arch Gynecol Obstet 280, 529-538 (2009).
11. Levy, G. et al. An update on adenomyosis. Diagnostic and interventional imaging 94, 3-25 (2013).
12. Lousse, J. C. et al. Peritoneal endometriosis is an inflammatory disease. Front Biosci (Elite Ed) 4, 23-40 (2012).
13. Kajihara, H. et al. New insights into the pathophysiology of endometriosis: From chronic inflammation to danger signal. Gynecol Endocrinol 27, 73-79 (2011).
14. Takeda, K., Akira, S. Toll-like receptors in innate immunity. Int Immunol 17, 1-14 (2005).
15. Sheldon, I. M., Bromfield, J. J. Innate immunity in the human endometrium and ovary. Am J Reprod Immunol 661, 63-71 (2011).
16. Kodati, V. L., Govindan, S., Movva, S., Ponnala, S., Hasan, Q. Role of shigella infection in endometriosis: A novel hypothesis. Med Hypotheses 70, 239-243 (2008).
17. Khan, K. N. et al. Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosis. Fertil Steril 94, 1803-2860 (2010).
18. Andersen, B. et al. Mycoplasma genitalium: Prevalence and behavioural risk factors in the general population. Sex Transm Infect 83, 237-241 (2007).
19. Sethi, S., Singh, G., Samanta, P., Sharma, M. Mycoplasma genitalium: An emerging sexually transmitted pathogen. Indian J Med Res 136, 942-955 (2012).
20. Williams, E. J. et al. Effect of Escherichia coli infection of the bovine uterus from the whole animal to the cell. Animal 2, 1153-1157 (2008).
21. Larsen, B., Galask, R. P. Vaginal microbial flora: Practical and theoretic relevance. Obstet Gynecol 55, 100S-113S (1980).
22. Burke, J. P. et al. Bacterial lipopolysaccharide promotes profibrotic activation of intestinal fibroblasts. Br J Surg 97, 1126-1134 (2010).
23. Peterman, T. A., Curran, J. W. Sexual transmission of human immunodeficiency virus. Jama 256, 2222-2226 (1986).
24. Beutler, B., Hoebe, K., Du X., Ulevitch, R. J. How we detect microbes and respond to them: The Toll-like receptors and their transducers. J Leukoc Biol 74, 479-485 (2003).
25. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282, 2085-2088 (1998).
26. Yu, L., Wang, L., Chen, S. Toll-Like receptors, inflammation and tumor in the human female reproductive tract. Am J Reprod Immunol 62, 1-8 (2009).
27. Khan, K. N. et al. Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosis. Fertil Steril 94, 1803-2860 (2010).
28. Li, X., Jiang, S., Tapping, R. I. Toll-like receptor signaling in cell proliferation and survival. Cytokine 49, 1-9 (2010).
29. Rajaei, S. et al. Effect of 1,25(OH)2 vitamin D3 on cytokine production by endometrial cells of women with repeated implantation failure. Gynecol Endocrinol 28, 906-911 (2012).
30. Tavakoli, M. et al. Effects of 1,25(OH)2 vitamin D3 on cytokine production by endometrial cells of women with recurrent spontaneous abortion. Fertil Steril 96, 751-757 (2011).
31. Schutz, M., Teifel, M., Friedl, P. Establishment of a human placental endothelial cell line with extended life span after transfection with SV 40 T-antigens. Eur J Cell Biol 74, 315-320 (1997).
32. Mylonas, I. et al. Immunohistochemical analysis of steroid receptors and glycodelin a (PP14) in isolated glandular epithelial cells of normal human endometrium. Histochem Cell Biol 114, 405-411 (2000).
33. Taylor, C. R., Levenson, R. M. Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment II. Histopathology 49, 411-424 (2006).
34. Wolff, A. C. et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131, 18-43 (2007).
35. Armstrong, L. et al. Expression of functional toll-like receptor-2 and-4 on alveolar epithelial cells. Am J Respir Cell Mol Biol 31, 241-245 (2004).
36. Khan, K. N. et al. Toll-Like receptors in innate immunity: Role of bacterial endotoxin and Toll-Like receptor 4 in endometrium and endometriosis. Gynecol Obstet Inves 68, 40-52 (2009).
37. Fleer, A., Krediet, T. G. Innate immunity: Toll-like receptors and some more. Neonatology 92, 145-157 (2007).
38. Turner, M. L., Healey, G. D., Sheldon, I. M. Immunity and inflammation in the uterus. Reprod Domest Anim 474, 402-409 (2012).
39. Husseinzadeh, N., Davenport, S. M. Role of Toll-like receptors in cervical, endometrial and ovarian cancers: A review. Gynecol Oncol 135, 359-363 (2014).
40. Hickey, D. K., Patel, M. V., Fahey, J. V., Wira, C. R. Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: Stratification and integration of immune protection against the transmission of sexually transmitted infections. J Reprod Immunol 88, 185-194 (2011).
41. Khan, K. N., Kitajima, M., Fujishita, A., Nakashima, M., Masuzaki, H. Toll-like receptor system and endometriosis. J Obstet Gynaecol Re 39, 1281-1292 (2013).
42. Muroi, M., Tanamoto, K. IRAK-1-mediated negative regulation of Toll-like receptor signaling through proteasome-dependent downregulation of TRAF6. Biochim Biophys Acta 1823, 255-263 (2012).
43. Liew, F. Y., Xu, D., Brint, E. K., O'Neill, L. A. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 5, 446-458 (2005).
44. Allhorn, S., Boeing, C., Koch, A. A., Kimmig, R., Gashaw, I. TLR3 and TLR4 expression in healthy and diseased human endometrium. Reprod Biol Endocrin 6, (2008).
45. Oppelt, P. et al. Correlation of high-risk human papilloma viruses but not of herpes viruses or Chlamydia trachomatis with endometriosis lesions. Fertil Steril 93, 1778-1786 (2010).
46. Delbandi, A. A. et al. Eutopic and ectopic stromal cells from patients with endometriosis exhibit differential invasive, adhesive, and proliferative behavior. Fertil Steril 100, 761-769 (2013).
47. Seki, E. et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13, 1324-1332 (2007).
48. Defrere, S. et al. Insights into iron and nuclear factor-kappa B (NF-kappaB) involvement in chronic inflammatory processes in peritoneal endometriosis. Histol Histopathol 26, 1083-1092 (2011).
49. May, K. E. et al. Peripheral biomarkers of endometriosis: A systematic review. Hum Reprod Update 16, 651-674 (2010).
50. Khan, K. N. et al. Interleukin-6-and tumour necrosis factor alpha-mediated expression of hepatocyte growth factor by stromal cells and its involvement in the growth of endometriosis. Hum Reprod 20, 2715-2723 (2005).
51. Othman, E. et al. Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol 137, 240-246 (2008).
52. Omwandho, C. O., Konrad, L., Halis, G., Oehmke, F., Tinneberg, H. R. Role of TGF-betas in normal human endometrium and endometriosis. Hum Reprod 25, 101-109 (2010).
53. Lutz, M., Knaus, P. Integration of the TGF-beta pathway into the cellular signalling network. Cell Signal 14, 977-988 (2002).
54. Sato, H. et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 61-65 (1994).
55. Kitawaki, J. et al. Endometriosis: The pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol 83, 149-155 (2002).
56. Noble, L. S. et al. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab 82, 600-606 (1997).
57. Maia, H. J., Casoy, J., Valente, F. J. Is aromatase expression in the endometrium the cause of endometriosis and related infertility? Gynecol Endocrinol 25, 253-257 (2009).